| 名稱 | β-thalassemia mutation Reference Standard Ⅰ |
| 型號(hào) | CBPD0001 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | β-thalassemia mutation Reference Standard Ⅰ |
產(chǎn)品搜索
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 分子診斷標(biāo)準(zhǔn)品，選擇科佰生物
- 可視化觀察黑色素瘤早期轉(zhuǎn)移，鑒定出一種新的治療靶標(biāo)
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
- ATCC細(xì)胞的細(xì)胞破碎
- 偏頭痛治療靶點(diǎn)——CGRP與藥篩細(xì)胞模型
- 雙面PD1，Blocker已成卷王，agonist賽道你上車了嗎？
- FH標(biāo)準(zhǔn)品上新
- 免疫治療的下一個(gè)靶標(biāo)：腫瘤相關(guān)巨噬細(xì)胞？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0001β-thalassemia mutation Reference Standard Ⅰ
- 詳細(xì)內(nèi)容
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Mutation 1 | Variation site: Codon 39(C>T) |
| DNA Change: c.118C>T | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248004G>A | |
| Transcript: NM_000518.5 | |
| Mutation 2 | Variation site: IVS-I-110(G>A) |
| DNA Change: c.93-21G>A | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248050C>T | |
| Transcript: NM_000518.5 | |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. Codon 39(C>T) Heterozygous
Figure 2. IVS-I-110(G>A) Heterozygous |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)